Dr Catherine Orteu

• CH Orteu and C Denton. Scleromyxedema, Chapter 25 in Rheumatic diseases and the skin. Ed M Matucci-Cerinic, W Piette, Elsevier 2011
• CH Orteu and A Mehta. Fabry disease, Chapter 135 in Fitzpatrics Dermatology in General Medicine 8th Ed. Ed Goldsmith,Katz, Gilchrest,Paller,Leffell,Wolff. McGraw-Hill 2012
• CH Orteu. Dermatological Manifestations of Fabry disease, Chapter 14 in Fabry Disease. Ed. D Elstein, G Altarescu, M Beck, Springer 2010
• CH Orteu and JP Dutz. Localized Scleroderma, chapter 4.1 in Autoimmune diseases of the skin; pathogenesis, diagnosis, management. Ed. Hertl M, Springer- Verlag 2001 WienNewYork and revised 2nd Ed 2005, 3rd Ed 2010
• MHA Rustin and CH Orteu. Cutaneous anaphylaxis, chapter in Encyclopedia of Immunology (2nd edition), Ed. PJ Delves, IM Roitt , Academic Press Ltd. London.
• Hogarth V, Hughes D, Orteu CH. Pseudoacromegalic facial features in Fabry disease Clin Exp Dermatol. 2013 Mar;38(2):137-9.
• Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M, Morrone A, Cardinali G, Kovacs D, Aspite N, Linder D, Parini R, Feliciani C; Interdisciplinary Study Group on Fabry Disease (ISGF). Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. Br J Dermatol. 2012 Apr;166(4):712-20.
• Hughes DA, Malmenäs M, Deegan PB, Elliott PM, Ginsberg L, Hajioff D, Ioannidis AS, Orteu CH, Ramaswami U, West M, Pastores GM, Jenkinson C; FOS Investigators Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease.J Med Genet. 2012 Mar;49(3):212-20. doi: 10.1136/jmedgenet-2011-100407. Epub 2012 Feb 7.
• Hogarth V, Dhoat S, Mehta AB, Orteu CH. Late onset Fabry disease associated with Angiokeratoma of Fordyce and multiple cherry angiomas. Clin Exp Dermatol. 2010 in press
• Singh M, McNamara C, Child F, Orteu CH. A post-transplant complication. Clin Exp Dermatol. 2009 Mar;34(2):275-6.
• Salvestrini C, McGrath JA, Ozoemena L, Husain K, Buhamrah E, Sabery N, Leichtner A, Rufo PA, Perez-Atayde A, Orteu CH, Torrente F, Heuschkel RB, Thomson MA, Murch SH. Desquamative enteropathy and pyloric atresia without skin disease caused by a novel intracellular beta4 integrin mutation. J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):585-91.
• Orteu CH, Jansen T, Lidove O, Jaussaud R, Hughes DA, Pintos-Morell L, Ramaswami U, Parini R, Sunder-Plassman G, Beck M, Mehta AB, on behalf of the FOS investigators. Fabry Disease and the Skin: Data from FOS, the Fabry outcome survey. Br J Dermatol Aug 2007;157(2):331-7.
• Cox-Brinkman J, Vedder A, Hollak C, Richfield L, Orteu K, Wijburg F, Hammond P. Three-dimensional face shape in Fabry disease. Eur J Hum Genet. 2007 May;15(5):535-42
• Oâ Brien BA, Geng X, Orteu CH, Huang Y, Ghoreishi M, Zhang Y, Bush JA, Li G, Finegood DT, Dutz JP. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun.2006 Mar; 26 (2): 104-15
• Shergill B, Orteu CH, McBride SR, Rustin MH. Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin. Br J Dermatol 2005 Sep 153(3): 650-2
• Reed JR, Vukmanovic-Stejic M, Fletcher JM, Soares MV, Cook JE, Orteu CH, Jackson SE, Birch KE, FosterGR, Salmon M, Beverley PC, Rustin MH, Akbar AN. Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med.2004 May 17;199 (10):1433-43
• Eisman S, Orteu CH. Recalcitrant ertosive flexural lichen planus: successful treatment with a combination of thalidomide and 0.1% tacrolimus ointment. Clin Exp Dermatol 2004 May; 29(3):268-70
• Eisman S, Mehta A, Orteu CH. Case 3. Fabry disease. Clin Exp Dermatol 2003 Sep; 28 (5):569-70
• Kahlon R, Hu Y, Orteu CH, Kifayet A, Trudeau JD, Tan R, Dutz JP. Optimization of epicutaneous immunization for the induction of CTL. Vaccine 2003 Jun 20; 21 (21-22): 2890-9
• Scheel-Toellner D, Akbar AN, Pilling D, Orteu CH, Buckley CD, Wang K, Webb PR, Lord JM, Salmon M. Type I interferons inhibit the resolution of Chronic inflammation. Symp Soc Exp Biol.2000; 52:277-88
• CH Orteu, RD Sontheimer, JP Dutz. The pathophysiology of photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed. 2001 Jun;17(3):95-113.
• CH Orteu J Buchanan I Hutchison, IM Leigh, RH Bull. Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed? Br J Dermatol. 2001 Jun;144(6):1219-23.
• DI Orton, CH Orteu, MHA Rustin. Cytomegalovirus-associated gastric ulcer in an immunosuppressed patient with pemphigus vulgaris. Clin Exp Dermatol. 2001Mar:26(2):170-172Â
• CH Orteu, MHA Rustin, CA Sabin, E Oâ Toole, M Salmon, LW Poulter, AN Akbar. The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema. Clin Exp Immunol 2000; 122(2):150-156
• D Pilling, AN Akbar, J Girdlestone, CH Orteu, NJ Borthwick, N Amft, D Scheel-Toellner, CD Buckley, M Salmon. Interferon-ï ¢ mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 1999;29:1041-1050.
• CH Orteu, LW Poulter, MHA Rustin, CA Sabin, M Salmon, AN Akbar. The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J Immunol 1998;161:1619-1629.
• CH Orteu, W Li, MH Allen, NP Smith, JNWN Barker, SJ Whittaker. CD44 Variant expression in cutaneous T cell lymphoma. J Cutan Pathol 1997;24:342-349.
• CH Orteu, JM McGregor, SJ Whittaker, F Balzola, AJ Wakefield. Erythema elevatum diutinum and Crohn's disease: a common pathogenic role for measles virus? Arch Dermatol 1996;132:1523-1525
• CH Orteu, JR Hughes and MHA Rustin. Naevus lipomatosus cutaneus superficialis: overlap with connective tissue naevi. Acta Derm Venereol 1996;76:243-245 (letter)
• CH Orteu and MHA Rustin. 20 thickened fragile nails. Lancet 1996;347:662
• CH Orteu, JM McGregor, JR Almeyda, MHA Rustin. Recurrence of hyperhidrosis following endoscopic transthoracic sympathectomy: case report and review of the literature. Clin Exp Derm 1995;20:230-233
• Toms GC,McCarthy MI, Niven MJ, Orteu CH, King TT, Monson JP. Predicting relapse after transsphenopidal surgery for Cushingâ s disease. J Clin Endocrinol Metab. 1993 Feb;76(2):291-4
• Dhoat S, Orteu CH, Navarro C, Lidove O, Jansen T, Clarke J. Patients with Fabry disease with cutaneous vascular lesions have higher disease severity scores and more multisystem involvement: data from 1354 patients registered on FOS, the Fabry outcome survey. Br J Dermatol. 161 (suppl.1): 45, 2009
• Orteu CH, Mehta AB, Dhoat S, Hughes DA. Fabry disease and angiokeratoma corporis diffusum are not synonymous: Cutaneous vascular lesions and facial features in 100 patients with Fabry disease. Br J Dermatol 161 (suppl.1): 46, 2009
• Patalay R, Attard N, Orteu C. A rare type of localized scleroderma: Keloidal morpheaÂ
• J Am Acad Dermatol 2006,54 (3): AB77-AB77 Suppl.
• Jansen T, Bechara FG, Orteu CH, AltmeyerP, Mehta A, Beck M. The significance of lymphoedema in Fabry Disease. Acta Paediatr Suppl. 447:117, 2005
• Ismail F, Orteu C. Two cases of Fabry disease and response to enzyme replacement therapy Br J Dermatol 2003 149: Suppl 64 26
• JR Reed, M Vukmanovic-Stejic, J Cook, J Fletcher, CH Orteu, M Salmon, P Beverley, MHA Rustin, AN Akbar. Accelerated telomere erosion during cutaneous T cell mediated inflammation. Br J Dermatol 2004,151(68):11
• CH Orteu, T Jansen, M Beck, A Mehta,R Ricci, U Widmer; on behalf of the European FOS investigators Group. The Fabry Outcome Survey is a useful tool to document the natural history of Fabry disease. Br J Dermatol 2004,151(68):9
• CH Orteu, A Akbar, LW Poulter, MHA Rustin Over-expression of IL-15 and IFN-ï ¢ promote T cell survival in atopic eczema. Br J Dermatol 1999,140 (4):793
• CH Orteu, LW Poulter, AN Akbar, M Salmon and MHA Rustin Increased fibroblast numbers and IFN-ï ¢ï production in a resolving delayed -type hypersensitivity response. Immunology 1998 95 (Suppl 1): 27
• CH Orteu, A Akbar, MHA Rustin, LW Poulter T cell apoptosis in Mantoux reactions and atopic eczema J Invest Dermatol 1998;110 (4):640
• CH Orteu, A Akbar, MHA Rustin, LW Poulter T cell apoptosis in delayed type hypersensitivity reactions. Br J Dermatol 1998, 138 (4): 749
• CH Orteu, A Akbar, MHA Rustin, LW Poulter T cell apoptosis in delayed type hypersensitivity reactions and lesional atopic eczema. Immunology 1997;92 (Suppl 1):86
• CH Orteu, M Jarmulowicz, MA Johnson and WG Phillips. Perforating Granuloma Annulare in association with HIV infection. Br J Dermatol 1997; 137( Suppl 50):66
• CH Orteu, A Akbar, MHA Rustin, LW Poulter. Does failure to promote T cell apoptosis contribute to the chronicity of eczema? J Invest Dermatol 1997;108(4):663
• C Orteu, M Rustin, A Akbar, LW Poulter. Loss of Bcl-2 precedes the decay of T cell populations in resolving Mantoux reactions. J Invest Dermatol 1996;107(3):470
• FA Balzola, R Sim, CH Orteu, S Whittaker, J Lewin, RE Pounder, AJ Wakefield. Measles virus and cutaneous manifestations of Crohn's disease. Br J Dermatol 1996;135 Suppl 47:41-42
• CH Orteu and MHA Rustin. Experience with the HGM K1 continuous wave krypton/argon laser. Br J Dermatol 1995:133 Suppl 45;26-27
• CH Orteu, W Li, MH Allen, NP Smith, JNWN Barker, SJ Whittaker. CD44 Variant expression in cutaneous T cell lymphoma. Br J Dermatol 1995:132;649Â Â Â
• Toms GC, McCarthy MI, Niven MJ, Orteu CH, King TT, Monson JP. Predicting relapse after transsphenoidal surgery for Cushing's disease. Journal of Endocrinology 1991:129(suppl);132.
• Corbett M, Garland CJ, Greenidge E, Keatinge WR, Orteu CH, Salvage D & Tate J. Pattern of response of smooth muscle of isolated bovine coronary arteries to thromboxane A2 analogue. Journal of Physiology, 1985 :369;140.